RWM
AMGN icon

Ruedi Wealth Management’s Amgen AMGN Stock Holding History

Ruedi Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19
Closed -$5.92K – 72
2025
Q1 		$5.92K Hold
19
– – ﹤0.01% 201
2024
Q4 		$4.95K Hold
19
– – ﹤0.01% 213
2024
Q3 		$6.12K Sell
19
-11
-37% -$3.6K ﹤0.01% 200
2024
Q2 		$9.37K Buy
30
+11
+58% +$3.23K ﹤0.01% 186
2024
Q1 		$5.4K Hold
19
– – ﹤0.01% 194
2023
Q4 		$5.47K Buy
+19
New +$5.18K ﹤0.01% 167
2023
Q2 		– Sell
-76
Closed -$18.4K – 226
2023
Q1 		$18.4K Sell
76
-26
-25% -$6.38K 0.01% 126
2022
Q4 		$26.8K Buy
+102
New +$27.3K 0.02% 106

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ruedi Wealth Management's AMGN Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 19 shares — an estimated $5.92K sold.

Ruedi Wealth Management first reported a position in AMGN in Q4 2022 and held it in 8 quarters. The position peaked at $26.8K in Q4 2022. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 19 Amgen shares in Q2 2025, an estimated $5.92K.
  • Ruedi Wealth Management first reported a position in Amgen in Q4 2022 and held it in 8 quarters.
  • Ruedi Wealth Management's Amgen position peaked at $26.8K in Q4 2022.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.